Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication errors: hospital pharmacist perspective.

Henk-Jan Guchelaar1, Hadewig B B Colen, Mathijs D Kalmeijer

  • 1Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. h.j.guchelaar@lumc.nl

Drugs
|August 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant Allele.

JCO precision oncology·2026
Same author

Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Clinical pharmacokinetics·2026
Same author

Predictors of poor treatment tolerability in older patients receiving fluoropyrimidine-based chemotherapy: A prospective cohort study.

Journal of geriatric oncology·2026
Same author

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Clinical pharmacokinetics·2026
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
See all related articles

Medication errors cause significant harm and costs. Clinical pharmacists can improve medication safety by optimizing drug distribution and implementing risk assessment strategies.

Area of Science:

  • Pharmacy
  • Healthcare Quality Improvement
  • Patient Safety

Background:

  • Medication errors lead to substantial mortality, morbidity, and healthcare costs.
  • Risk assessment models are being adapted for clinical pharmacy from other industries.
  • Hospital pharmacists are central to overseeing the drug distribution chain and enhancing safety.

Purpose of the Study:

  • To discuss interventions for reducing medication errors.
  • To highlight the role of clinical pharmacists in improving medication safety.
  • To explore risk assessment in clinical pharmacy.

Main Methods:

  • Reviewing potential interventions for medication error reduction.
  • Discussing risk assessment models in clinical pharmacy.

Related Experiment Videos

  • Examining the optimization of the drug distribution chain.

    • Main Results:

    • Limited scientific evidence exists for the effectiveness of many medication safety interventions.
    • Clinical pharmacists can play a vital role at both organizational and individual patient care levels.
    • Methods for detecting high-risk patients and performing risk assessments are crucial.

    Conclusions:

    • Optimizing the drug distribution chain and implementing risk assessment are key to improving medication safety.
    • Clinical pharmacists are essential for enhancing patient safety and reducing medication errors.
    • Further research with comparative intervention studies is needed to demonstrate evidence-based improvements.